Supported in part by the National Institutes of Health/National Cancer Institute through Cancer Center Support Grant P30CA016672 to The University of Texas MD Anderson Cancer Center. P.M. and E.B.L.
Hydroxychloroquine, chloroquine, and remdesivir are among the drugs commonly discussed as treatments for the new viral infection, coronavirus disease 2019 (COVID-19). Previously, I described different ...
Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study Five hundred sixty patients with newly diagnosed MCL underwent a ...
Hydroxychloroquine, chloroquine, and remdesivir are among the drugs commonly discussed as treatments for the new viral infection, coronavirus disease 2019 (COVID-19). Previously, I described different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback